THOMAS WINEGARDEN: Open Payments
NPI 1194707828 · CHANHASSEN, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,724 in 35 payments from 11 companies in 2025. Trend: 2023 $101 · 2024 $15,033 · 2025 $16,724
Consulting: $9,775Speaker / faculty: $5,520Travel & lodging: $842Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $16,486 |
| Neuronetics, Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: COBENFY, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, Qelbree, FANAPT, REXULTI, ZEPBOUND, AUSTEDO XR.
Industry payments across MN — which companies pay providers there.
